Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022

Medicines for Europe is part of the REMEDi4ALL consortium! An EU-funded research initiative aiming at driving forward the repurposing of medicines in Europe

2 September 2022

REMEDi4ALL launched yesterday with the aim of making a major […]

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022